相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comparison of irinotecan/platinum versus etoposide/platinum chemotherapy for extensive-stage small cell lung cancer: A meta-analysis
D. Han et al.
EUROPEAN JOURNAL OF CANCER CARE (2017)
h Cisplatin combined with irinotecan or etoposide for untreated extensive-stage small cell lung cancer: A multicenter randomized controlled clinical trial
Yuankai Shi et al.
THORACIC CANCER (2015)
Prognostic Value of CD44 Variant exon 6 Expression in Non-Small Cell Lung Cancer: a Meta-analysis
Shuang Zhao et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Clinical significance of putative cancer stem cell marker CD44 in different histological subtypes of lung cancer
Raheleh Roudi et al.
CANCER BIOMARKERS (2014)
Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer
Muhammad Alamgeer et al.
BREAST CANCER RESEARCH (2014)
Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity
Elisa Dalla Pozza et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2013)
Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors
Shanthi Ganesh et al.
BIOMATERIALS (2013)
Cancer Stem-like Cell Marker CD44 Promotes Bone Metastases by Enhancing Tumorigenicity, Cell Motility, and Hyaluronan Production
Toru Hiraga et al.
CANCER RESEARCH (2013)
CD44 Expression in Intestinal Epithelium and Colorectal Cancer Is Independent of p53 Status
Jurrit Zeilstra et al.
PLOS ONE (2013)
The prognostic significance of aldehyde dehydrogenase 1A1 (ALDH1A1) and CD133 expression in early stage non-small cell lung cancer
Muhammad Alamgeer et al.
THORAX (2013)
Prognostic Impact of Circulating Tumor Cells in Patients with Small Cell Lung Cancer
Tateaki Naito et al.
JOURNAL OF THORACIC ONCOLOGY (2012)
A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancer
A. Schmittel et al.
ANNALS OF ONCOLOGY (2011)
Hyaluronan-Irinotecan improves progression-free survival in 5-fluorouracil refractory patients with metastatic colorectal cancer: a randomized phase II trial
Peter Gibbs et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Hyaluronan-CD44 interactions as potential targets for cancer therapy
Suniti Misra et al.
FEBS JOURNAL (2011)
Small-cell lung cancer
Jan P. van Meerbeeck et al.
LANCET (2011)
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
Margot Zoeller
NATURE REVIEWS CANCER (2011)
A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease
P. Zatloukal et al.
ANNALS OF ONCOLOGY (2010)
CD44, a therapeutic target for metastasising tumours
Veronique Orian-Rousseau
EUROPEAN JOURNAL OF CANCER (2010)
A Pilot Human Evaluation of a Formulation of Irinotecan and Hyaluronic Acid in 5-Fluorouracil-Refractory Metastatic Colorectal Cancer Patients
Peter Gibbs et al.
CHEMOTHERAPY (2009)
Phase II Trial of Irinotecan and Carboplatin for Extensive or Relapsed Small-Cell Lung Cancer
Gigi Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124
Primo N. Lara et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer:: A Randomized phase III trial
Andreas Hermes et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
Hyaluronic acid-paclitaxel: Antitumor efficacy against CD44(+) human ovarian carcinoma xenografts
Edmond Auzenne et al.
NEOPLASIA (2007)
Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer
N Hanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin
MB Brown et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2005)
Phase I and pharmacokinetic evaluation of intravenous hyaluronic acid in combination with doxorubicin or 5-fluorouracil
MA Rosenthal et al.
CHEMOTHERAPY (2005)
Weekly administration of irinotecan (CPT-11) plus cisplatin for refractory or relapsed small cell lung cancer
M Ando et al.
LUNG CANCER (2004)
Phase II study of topotecan and paclitaxel for patients with previously untreated extensive stage small-cell lung cancer
S Ramalingam et al.
ANNALS OF ONCOLOGY (2004)
Recent advances in management of small-cell lung cancer
YJ Chua et al.
CANCER TREATMENT REVIEWS (2004)
Treatment of small cell lung cancer
A Kurup et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)
Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
WJ Allard et al.
CLINICAL CANCER RESEARCH (2004)
CD44: From adhesion molecules to signalling regulators
H Ponta et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer
W Noda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Chemotherapy as treatment of primary and recurrent small cell lung cancer
W Schuette
LUNG CANCER (2001)
A crucial role for CD44 in inflammation
E Puré et al.
TRENDS IN MOLECULAR MEDICINE (2001)
Isoform expression of CD44 adhesion molecules, Bcl-2. p53 and Ki-67 proteins in lung cancer
E Mizera-Nyczak et al.
TUMOR BIOLOGY (2001)
分享论文
